Bacellar H, Muñoz A, Hoover D R, Phair J P, Besley D R, Kingsley L A, Vermund S H
Johns Hopkins School of Public Health, Baltimore, MD 21205.
J Infect Dis. 1994 Nov;170(5):1284-7. doi: 10.1093/infdis/170.5.1284.
Incidence rates of AIDS illnesses are described among patients with < or = 100 CD4 cells/mm3 grouped by use of antiretrovirals and chemoprophylaxis. Data were obtained from 2646 homosexual men infected with human immunodeficiency virus type 1. Participants were in the Multicenter AIDS Cohort Study during 1985-1993. The incidence rates per 100 person-years for Pneumocystis carinii pneumonia were 47.4 without treatment, 21.5 with antiretrovirals alone, and 12.8 with antiretrovirals combined with chemoprophylaxis. For Kaposi's sarcoma these rates were 23.2, 11.3, and 15.1, respectively. The incidence of some opportunistic infections, including Mycobacterium avium complex, nonretinitis cytomegalovirus disease, and cytomegalovirus retinitis, increased among persons receiving P. carinii pneumonia prophylaxis, because of reduction of this pneumonia and extension of life span. The incidence pattern of AIDS-defining illnesses in patients receiving treatment points to the changing AIDS epidemic and the need for new therapies. The data are particularly relevant to the development and planning of clinical trials and to health care providers.
根据抗逆转录病毒药物的使用情况和化学预防措施,对CD4细胞计数≤100个/mm³的患者中艾滋病相关疾病的发病率进行了描述。数据来自2646名感染1型人类免疫缺陷病毒的同性恋男性。参与者于1985年至1993年期间参加了多中心艾滋病队列研究。卡氏肺孢子虫肺炎每100人年的发病率在未治疗时为47.4,仅使用抗逆转录病毒药物时为21.5,使用抗逆转录病毒药物联合化学预防时为12.8。卡波西肉瘤的发病率分别为23.2、11.3和15.1。在接受卡氏肺孢子虫肺炎预防的人群中,包括鸟分枝杆菌复合体、非视网膜巨细胞病毒病和巨细胞病毒性视网膜炎在内的一些机会性感染的发病率有所增加,这是由于这种肺炎的减少和寿命的延长。接受治疗的患者中艾滋病定义疾病的发病模式表明了艾滋病流行情况的变化以及对新疗法的需求。这些数据与临床试验的开展和规划以及医疗服务提供者特别相关。